Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

SAREPTA THERAPEUTICS

Filed by TARPLIN, DOWNS & YOUNG, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Amendment
Posted
Jan 21, 2026
Income
$90,000.00
Expenses
Not reported
Filing UUID
88c2f4eb-7662-4771-b5a2-def60319da0d
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

federal budget issues

HCR · Health Issues

innovation, Duchenne Muscular Dystrophy, platform technologies, value based contracting, gene therapy

MMM · Medicare/Medicaid

Medicaid drug rebate program, coverage, state program operations, waivers, gene therapy, value based contracting, Medicaid value based payment rule

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.